{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:54:47Z","timestamp":1793310887757,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pathol Microbiol"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijpm.ijpm_465_17","type":"journal-article","created":{"date-parts":[[2018,7,13]],"date-time":"2018-07-13T08:06:54Z","timestamp":1531469214000},"page":"323","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of human epididymal secretory protein 4 expression according to the molecular subtypes (luminal A, luminal B, human epidermal growth factor receptor 2-positive, triple-negative) of breast cancer"],"prefix":"10.4103","volume":"61","author":[{"given":"Gulden","family":"Diniz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze","family":"Akoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeyye","family":"Ekmekci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZubeydeYildirim","family":"Ekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melek","family":"Uncel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0377-4929.236613-1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/0377-4929.236613-2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/gyno.1996.0191","article-title":"Clinical value of CA125, CA19-9, CEA, CA72-4, and TPA in borderline ovarian tumor","author":"Tamakoshi","year":"1996","journal-title":"Gynecol Oncol"},{"key":"key-10.4103\/0377-4929.236613-3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","article-title":"A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitor","author":"Kirchoff","year":"1991","journal-title":"Biol Reprod"},{"key":"key-10.4103\/0377-4929.236613-4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","author":"Bingle","year":"2006","journal-title":"Respir Res"},{"key":"key-10.4103\/0377-4929.236613-5","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","author":"Drapkin","year":"2005","journal-title":"Cancer Res"},{"key":"key-10.4103\/0377-4929.236613-6","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","author":"Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res"},{"key":"key-10.4103\/0377-4929.236613-7","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"key-10.4103\/0377-4929.236613-8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.humpath.2012.07.017","article-title":"Human epididymis protein 4 is up-regulated in gastric and pancreatic adenocarcinomas","author":"O'Neal","year":"2013","journal-title":"Hum Pathol"},{"key":"key-10.4103\/0377-4929.236613-9","first-page":"4779","article-title":"HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer","author":"Kamei","year":"2010","journal-title":"Anticancer Res"},{"key":"key-10.4103\/0377-4929.236613-10","first-page":"61","article-title":"Comprehensive molecular portraits of human breast tumours","author":"Cancer","year":"2012","journal-title":"Nature"},{"key":"key-10.4103\/0377-4929.236613-11","unstructured":"Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF. SEER cancer statistics review, 1975-2011. Based on November 2013 SEER Data Submission, Posted to the SEER Web Site. Bethesda (MD): National Cancer Institute; 2014."},{"key":"key-10.4103\/0377-4929.236613-12","doi-asserted-by":"crossref","unstructured":"Rosai J. Breast. In: Ackerman and Rosai Surgical Pathology. Philadelphia: Mosby; 2011. p. 1659-770.","DOI":"10.1016\/B978-0-323-06969-4.00029-5"},{"key":"key-10.4103\/0377-4929.236613-13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"key-10.4103\/0377-4929.236613-14","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","author":"S\u00f8rlie","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/0377-4929.236613-15","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/1055-9965.EPI-14-0447","article-title":"HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: A systematic review","author":"Karlsen","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"key-10.4103\/0377-4929.236613-16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.18632\/oncotarget.6327","article-title":"Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"key-10.4103\/0377-4929.236613-17","doi-asserted-by":"crossref","first-page":"12389","DOI":"10.1007\/s13277-014-2553-1","article-title":"Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer","author":"Vallius","year":"2014","journal-title":"Tumour Biol"},{"key":"key-10.4103\/0377-4929.236613-18","first-page":"5568","article-title":"Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer","author":"Jiang","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"key-10.4103\/0377-4929.236613-19","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s13277-014-2858-0","article-title":"The human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancer","author":"Guo","year":"2015","journal-title":"Tumour Biol"},{"key":"key-10.4103\/0377-4929.236613-20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/mco.2016.919","article-title":"A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study","author":"G\u00fcnd\u00fcz","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"key-10.4103\/0377-4929.236613-21","unstructured":"Donegan WL. History of breast cancer. In: Breast Cancer. Ontario: BC Decker Inc.; 2006. p. 1-14."},{"key":"key-10.4103\/0377-4929.236613-22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00428-014-1593-7","article-title":"Molecular classification of breast cancer","author":"Vuong","year":"2014","journal-title":"Virchows Arch"}],"container-title":["Indian Journal of Pathology and Microbiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:35:32Z","timestamp":1786714532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJPM.IJPM_465_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["236613"],"URL":"https:\/\/doi.org\/10.4103\/ijpm.ijpm_465_17","relation":{},"ISSN":["0377-4929"],"issn-type":[{"value":"0377-4929","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}